Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Salma Mortada, Mohcine Missioui, Walid Guerrab, Güneş Demirtaş, Joel T. Mague, My El Abbes Faouzi & Youssef Ramli. (2023) New styrylquinoxaline: synthesis, structural, biological evaluation, ADMET prediction and molecular docking investigations. Journal of Biomolecular Structure and Dynamics 41:7, pages 2861-2877.
Read now
Read now
Rajneesh Paul Sharma, Sheena Mahajan, Nancy Slathia & Kamal K. Kapoor. (2022) FeCl3 as an efficient catalyst for the synthesis of styrylquinoxalin-2(1H)-ones. Synthetic Communications 52:7, pages 1069-1078.
Read now
Read now
Gavaskar Deivasigamani & Suresh Babu Adukamparai Rajukrishnan. (2021) A sequential multicomponent reaction (SMCR) strategy: Synthesis of novel pyrazolo-1,4-dioxaspiro[4,5]decane grafted spiro-indenoquinoxaline pyrrolidine heterocycles. Synthetic Communications 51:13, pages 2063-2076.
Read now
Read now
Ming Bian, Qian-qian Ma, Yun Wu, Huan-huan Du & Gong Guo-hua. (2021) Small molecule compounds with good anti-inflammatory activity reported in the literature from 01/2009 to 05/2021: a review. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 2139-2159.
Read now
Read now
Articles from other publishers (16)
He WeiGang, Liu KaiQiang, Hou XueYou, Xu JiaHan, Zhi TaiXin, Deng YingKai, Hu JunYi, Jin MoYan, Wang JiaChen, Wang Xin & Sun XianYu. (2023) Therapeutic potential of a triazole curcumin in inflammation: Decreased LPS-induced acute lung injury in mice by targeting MD2/TLR4. Arabian Journal of Chemistry 16:9, pages 105076.
Crossref
Crossref
Gita Chawla, Ojasvi Gupta & Tathagata Pradhan. (2023) A Review on Multipurpose Potential of Bioactive Heterocycle Quinoxaline. ChemistrySelect 8:29.
Crossref
Crossref
Cindy Patinote, Sandy Raevens, Amélie Baumann, Eloise Pellegrin, Pierre-Antoine Bonnet & Carine Deleuze-Masquéfa. (2023) [1,2,4]triazolo[4,3-a]quinoxaline as Novel Scaffold in the Imiqualines Family: Candidates with Cytotoxic Activities on Melanoma Cell Lines. Molecules 28:14, pages 5478.
Crossref
Crossref
Vikas V. Khade, Anindita Bhowmick, Archana S. Thube & Ramakrishna G. Bhat. (2023) Direct Access to Strained Fused Dihalo-Aziridino Quinoxalinones via C3-Alkylation Followed by Tandem Cyclization. The Journal of Organic Chemistry 88:13, pages 8010-8023.
Crossref
Crossref
Inci Selin Doğan, Bahittin Kahveci, Suat Sari, Kübra Kolci, Rengin Reis & Hande SIPAHI. (2022) Synthesis, Molecular Modelling and In Vitro Anti‐inflammatory Activity of Novel 1,2,4‐Triazolo[4,3‐a]quinoxaline Derivatives. ChemistrySelect 7:26.
Crossref
Crossref
Asim Kumar, Tejas M. Dhameliya, Kirti Sharma, Krupa A. Patel, Rajvi V. Hirani & Aditi J. Bhatt. (2022) Sustainable approaches towards the synthesis of quinoxalines: An update. Journal of Molecular Structure 1259, pages 132732.
Crossref
Crossref
Tanu Kaushal, Sana Khan, Kaneez Fatima, Suaib Luqman, Feroz Khan & Arvind Singh Negi. (2022) Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline
Derivatives as Potent Anticancer Agents against Triple-negative Breast
Cancer. Current Topics in Medicinal Chemistry 22:10, pages 855-867.
Crossref
Crossref
Sulaksha R. Desai, Vidya G. Desai & Raghuvir R. Pissurlenkar. (2022) Design, synthesis and molecular docking studies of new azomethine derivatives as promising anti-inflammatory agents. Bioorganic Chemistry 120, pages 105595.
Crossref
Crossref
Xiaoying Jiang, Kaiyu Wu, Renren Bai, Pengfei Zhang & Yi Zhang. (2022) Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities. European Journal of Medicinal Chemistry 229, pages 114085.
Crossref
Crossref
Mohcine Missioui, Musa A. Said, Güneş Demirtaş, Joel T. Mague, Ahlam Al-Sulami, Nadia S. Al-Kaff & Youssef Ramli. (2022) A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity. Arabian Journal of Chemistry 15:2, pages 103595.
Crossref
Crossref
Qianqian Ma, Ming Bian, Guohua Gong, Chunmei Bai, Chunyan Liu, Chengxi Wei, Zhe-shan Quan & Huan-huan Du. (2022)
Synthesis and Evaluation of Bakuchiol Derivatives as Potent Anti-inflammatory Agents
in Vitro
and
in Vivo
. Journal of Natural Products 85:1, pages 15-24.
Crossref
Crossref
Mohcine Missioui, Musa A. Said, Güneş Demirtaş, Joel T. Mague & Youssef Ramli. (2022) Docking of disordered independent molecules of novel crystal structure of (N-(4-methoxyphenyl)-2-(3-methyl-2-oxo-3,4-dihydroquinoxalin-1(2H)-yl)acetamide as anti-COVID-19 and anti-Alzheimer's disease. Crystal structure, HSA/DFT/XRD. Journal of Molecular Structure 1247, pages 131420.
Crossref
Crossref
Sajjad H. Sumrra, Wardha Zafar, Hassan Javed, Muddassar Zafar, Muhammad Z. Hussain, Muhammad Imran & Muhammad A. Nadeem. (2021) Facile synthesis, spectroscopic evaluation and antimicrobial screening of metal endowed triazole compounds. BioMetals 34:6, pages 1329-1351.
Crossref
Crossref
Ali Irfan, Sajjad Ahmad, Saddam Hussain, Fozia Batool, Haseeba Riaz, Rehman Zafar, Katarzyna Kotwica-Mojzych & Mariusz Mojzych. (2021) Recent Updates on the Synthesis of Bioactive Quinoxaline-Containing Sulfonamides. Applied Sciences 11:12, pages 5702.
Crossref
Crossref
Nadeem Abad, Hamdi Hamid Sallam, Fares Hezam Al-Ostoot, Hussien Ahmed Khamees, Sultan A. Al-horaibi, Sridhar M. A, Shaukath Ara Khanum, Mahendra Madegowda, Mohamed El Hafi, Joel T. Mague, El Mokhtar Essassi & Youssef Ramli. (2021) Synthesis, crystal structure, DFT calculations, Hirshfeld surface analysis, energy frameworks, molecular dynamics and docking studies of novel isoxazolequinoxaline derivative (IZQ) as anti-cancer drug. Journal of Molecular Structure 1232, pages 130004.
Crossref
Crossref
Ruimei Zhou, Mingxiao Cui, Yu Wang, Min Zhang, Feifei Li & Kehai Liu. (2020) Isolation, structure identification and anti-inflammatory activity of a polysaccharide from Phragmites rhizoma. International Journal of Biological Macromolecules 161, pages 810-817.
Crossref
Crossref